Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 549136, 8 pages
http://dx.doi.org/10.1155/2014/549136
Review Article

Stem Cell Based Gene Therapy in Prostate Cancer

1Department of Urology, Soonchunhyang University, College of Medicine, Soonchunyang University Hospital, Seoul 140-743, Republic of Korea
2Medical Research Institute, Chung-Ang School of Medicine, Seoul 156-756, Republic of Korea

Received 6 March 2014; Accepted 2 July 2014; Published 10 July 2014

Academic Editor: Jeremy Clark

Copyright © 2014 Jae Heon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Pulkkanen and S. Yla-Herttuala, “Gene therapy for malignant glioma: current clinical status,” Molecular Therapy, vol. 12, no. 4, pp. 585–598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Cihova, V. Altanerova, and C. Altaner, “Stem cell based cancer gene therapy,” Molecular Pharmaceutics, vol. 8, no. 5, pp. 1480–1487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Zarogoulidis, K. Darwiche, A. Sakkas et al., “Suicide gene therapy for cancer—current strategies,” Journal of Genetic Syndrome & Gene Therapy, vol. 9, p. 4, 2013. View at Publisher · View at Google Scholar
  4. S. Bobis, D. Jarocha, and M. Majka, “Mesenchymal stem cells: characteristics and clinical applications,” Folia Histochemica et Cytobiologica, vol. 44, no. 4, pp. 215–230, 2006. View at Google Scholar · View at Scopus
  5. C. V. Borlongan, Y. Kaneko, M. Maki et al., “Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke,” Stem Cells and Development, vol. 19, no. 4, pp. 439–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. P. Murphy, H. Wang, A. N. Patel et al., “Allogeneic endometrial regenerative cells: an “Off the shelf solution” for critical limb ischemia?” Journal of Translational Medicine, vol. 6, article 45, 2008. View at Publisher · View at Google Scholar
  7. M. D. Griffin, T. Ritter, and B. P. Mahon, “Immunological aspects of allogeneic mesenchymal stem cell therapies,” Human Gene Therapy, vol. 21, no. 12, pp. 1641–1655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. R. Koppula, L. K. Chelluri, N. Polisetti, and G. K. Vemuganti, “Histocompatibility testing of cultivated human bone marrow stromal cells—a promising step towards pre-clinical screening for allogeneic stem cell therapy,” Cellular Immunology, vol. 259, no. 1, pp. 61–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. le Blanc, “Immunomodulatory effects of fetal and adult mesenchymal stem cells,” Cytotherapy, vol. 5, no. 6, pp. 485–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Lin and WJ. Hogan, “Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease,” Advances in Hematology, vol. 2011, Article ID 427863, 17 pages, 2011. View at Publisher · View at Google Scholar
  11. K. S. Aboody, R. A. Bush, E. Garcia et al., “Development of a tumor-selective approach to treat metastatic cancer,” PLoS ONE, vol. 1, no. 1, article e23, 2006. View at Publisher · View at Google Scholar
  12. F. H. Gage, “Mammalian neural stem cells,” Science, vol. 287, no. 5457, pp. 1433–1438, 2000. View at Publisher · View at Google Scholar
  13. M. K. Danks, K. J. Yoon, R. A. Bush et al., “Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma,” Cancer Research, vol. 67, no. 1, pp. 22–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kim, S. U. Kim, I. H. Park et al., “Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression,” Clinical Cancer Research, vol. 12, no. 18, pp. 5550–5556, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Shimato, A. Natsume, H. Takeuchi et al., “Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma,” Gene Therapy, vol. 14, no. 15, pp. 1132–1142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. S. Aboody, J. Najbauer, M. Z. Metz et al., “Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies,” Science Translational Medicine, vol. 5, no. 184, Article ID 184ra59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Han, X. Meng, Z. Yin et al., “Inhibition of intracranial glioma growth by endometrial regenerative cells,” Cell Cycle, vol. 8, no. 4, pp. 606–610, 2009. View at Publisher · View at Google Scholar
  18. T. S. Lawrence, M. A. Davis, and J. Maybaum, “Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects,” International Journal of Radiation Oncology Biology Physics, vol. 29, no. 3, pp. 519–523, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. L. D. Stegman, A. Rehemtulla, B. Beattie et al., “Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9821–9826, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Jacobs, J. Voges, R. Reszka et al., “Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas,” The Lancet, vol. 358, no. 9283, pp. 727–729, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Penuelas, G. Mazzolini, J. F. Boan et al., “Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients,” Gastroenterology, vol. 128, no. 7, pp. 1787–1795, 2005. View at Publisher · View at Google Scholar
  22. V. Altanerova, M. Cihova, M. Babic et al., “Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma,” International Journal of Cancer, vol. 130, no. 10, pp. 2455–2463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Lee, S. W. Doo, D. H. Kim et al., “Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice,” Cancer Letters, vol. 335, no. 1, pp. 58–65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. G. Menon, K. Kelly, H. W. Yang, S. K. Kim, P. M. Black, and R. S. Carroll, “Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy,” Stem Cells, vol. 27, no. 9, pp. 2320–2330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. C. Hung, W. P. Deng, W. K. Yang et al., “Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging,” Clinical Cancer Research, vol. 11, no. 21, pp. 7749–7756, 2005. View at Publisher · View at Google Scholar
  26. E. L. Spaeth, J. L. Dembinski, A. K. Sasser et al., “Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression,” PLoS ONE, vol. 4, no. 4, Article ID e4992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Suzuki, R. Sun, M. Origuchi et al., “Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization,” Molecular Medicine, vol. 17, no. 7-8, pp. 579–587, 2011. View at Google Scholar
  28. W. Zhu, L. Huang, Y. Li et al., “Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth,” Cell Cycle, vol. 10, no. 18, pp. 3198–3207, 2011. View at Publisher · View at Google Scholar
  29. K. Kawamura, K. Tasaki, H. Hamada, K. Takenaga, S. Sakiyama, and M. Tagawa, “Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity,” Cancer Gene Therapy, vol. 7, no. 4, pp. 637–643, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Li, T. Tokuyama, J. Yamamoto, M. Koide, N. Yokota, and H. Namba, “Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells,” Cancer Gene Therapy, vol. 12, no. 7, pp. 600–607, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Stefani, L. Barzon, I. Castagliuolo et al., “Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma,” Journal of Hepatology, vol. 42, no. 5, pp. 728–735, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. I. T. Cavarretta, V. Altanerova, M. Matuskova, L. Kucerova, Z. Culig, and C. Altaner, “Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth,” Molecular Therapy, vol. 18, no. 1, pp. 223–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Altaner, “Prodrug cancer gene therapy,” Cancer letters, vol. 270, no. 2, pp. 191–201, 2008. View at Google Scholar
  34. L. Kucerova, V. Altanerova, M. Matuskova, S. Tyciakova, and C. Altaner, “Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy,” Cancer Research, vol. 67, no. 13, pp. 6304–6313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Y. Khakoo, S. Pati, S. A. Anderson et al., “Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma,” The Journal of Experimental Medicine, vol. 203, no. 5, pp. 1235–1247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Qiao, Z. L. Xu, T. J. Zhao, L. H. Ye, and X. D. Zhang, “Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling,” Cancer Letters, vol. 269, no. 1, pp. 67–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Karp and G. S. Leng Teo, “Mesenchymal stem cell homing: the devil is in the details,” Cell Stem Cell, vol. 4, no. 3, pp. 206–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Kucerova, M. Matuskova, K. Hlubinova, V. Altanerova, and C. Altaner, “Tumor cell behaviour modulation by mesenchymal stromal cells,” Molecular Cancer, vol. 9, article 129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Y. Lee, T. Zhang, C. P. Lau, C. C. Wang, K. M. Chan, and G. Li, “Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo,” Cytotherapy, vol. 15, no. 12, pp. 1484–1497, 2013. View at Publisher · View at Google Scholar
  40. K. S. Aboody, J. Najbauer, and M. K. Danks, “Stem and progenitor cell-mediated tumor selective gene therapy,” Gene Therapy, vol. 15, no. 10, pp. 739–752, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. U. Fischer, S. Steffens, S. Frank, N. G. Rainov, K. Schulze-Osthoff, and C. M. Kramm, “Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells,” Oncogene, vol. 24, no. 7, pp. 1231–1243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Kanai, T. Kawakami, H. Hamada et al., “Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil,” Cancer Research, vol. 58, no. 9, pp. 1946–1951, 1998. View at Google Scholar · View at Scopus
  43. X. X. Sun, M. S. Dai, and H. Lu, “5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction,” The Journal of Biological Chemistry, vol. 282, no. 11, pp. 8052–8059, 2007. View at Google Scholar
  44. E. Kievit, M. K. Nyati, E. Ng et al., “Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts,” Cancer Research, vol. 60, no. 23, pp. 6649–6655, 2000. View at Google Scholar · View at Scopus
  45. P. Erbs, E. Regulier, J. Kintz et al., “In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene,” Cancer Research, vol. 60, no. 14, pp. 3813–3822, 2000. View at Google Scholar · View at Scopus
  46. B. Yi, K. Hwang, Y. Kim, S. U. Kim, and K. Choi, “Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP prostate cancer cells,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 12519–12532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. F. L. Moolten and J. M. Wells, “Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors,” Journal of the National Cancer Institute, vol. 82, no. 4, pp. 297–300, 1990. View at Publisher · View at Google Scholar · View at Scopus
  48. M. T. Tomicic, R. Thust, and B. Kaina, “Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation,” Oncogene, vol. 21, no. 14, pp. 2141–2153, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Abate-Daga, L. Garcia-Rodríguez, L. Sumoy, and C. Fillat, “Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1803, no. 10, pp. 1175–1185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Beltinger, S. Fulda, T. Kammertoens, E. Meyer, W. Uckert, and K. Debatin, “Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8699–8704, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Song, J. Xiang, J. Tang et al., “Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy,” Human Gene Therapy, vol. 22, no. 4, pp. 439–449, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Ren, S. Kumar, D. Chanda et al., “Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model,” Gene Therapy, vol. 15, no. 21, pp. 1446–1453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Y. Chang, S. W. Yoo, Y. Hong et al., “The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase,” International Journal of Cancer, vol. 127, no. 8, pp. 1975–1983, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Zhang, A. C. Daquinag, F. Amaya-Manzanares, O. Sirin, C. Tseng, and M. G. Kolonin, “Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment,” Cancer Research, vol. 72, no. 20, pp. 5198–5208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Tanaka, H. Kawashima, K. Matsumura et al., “Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer,” Oncology Reports, vol. 21, no. 1, pp. 33–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Mizutani, H. Wada, M. Fukushima et al., “Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma,” Cancer, vol. 100, no. 4, pp. 723–731, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Hall, M. Andreeff, and F. Marini, “The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles,” in Bone Marrow-Derived Progenitors, vol. 180 of Handbook of Experimental Pharmacology, pp. 263–283, Springer, Berlin, Germany, 2007. View at Publisher · View at Google Scholar
  58. W. Zhu, W. Xu, R. Jiang et al., “Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo,” Experimental and Molecular Pathology, vol. 80, no. 3, pp. 267–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. L. B. Ohlsson, L. Varas, C. Kjellman, K. Edvardsen, and M. Lindvall, “Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix,” Experimental and Molecular Pathology, vol. 75, no. 3, pp. 248–255, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Ramasamy, E. W. Lam, I. Soeiro, V. Tisato, D. Bonnet, and F. Dazzi, “Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth,” Leukemia, vol. 21, no. 2, pp. 304–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. C. H. Ryu, K. Y. Park, S. M. Kim et al., “Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma,” Biochemical and Biophysical Research Communications, vol. 421, no. 3, pp. 585–590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. S. François, M. Bensidhoum, M. Mouiseddine et al., “Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage,” Stem Cells, vol. 24, no. 4, pp. 1020–1029, 2006. View at Publisher · View at Google Scholar · View at Scopus